Have EHealth Insiders Been Selling Stock?
Have EHealth Insiders Been Selling Stock?
Anyone interested in eHealth, Inc. (NASDAQ:EHTH) should probably be aware that the Independent Director, Dale Wolf, recently divested US$105k worth of shares in the company, at an average price of US$5.25 each. That sale was 14% of their holding, so it does make us raise an eyebrow.
任何對易康公司(納斯達克:EHTH)感興趣的人可能應該知道,獨立董事戴爾·沃爾夫最近出售了價值105000美元的股份,平均售價爲每股5.25美元。這次出售佔他們持股的14%,因此確實讓我們 raised an eyebrow。
The Last 12 Months Of Insider Transactions At eHealth
過去12個月的內部交易情況
The CEO & Director Francis Soistman made the biggest insider purchase in the last 12 months. That single transaction was for US$204k worth of shares at a price of US$4.07 each. Even though the purchase was made at a significantly lower price than the recent price (US$4.78), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.
首席執行官兼董事弗朗西斯·索伊斯特曼在過去的12個月中進行了最大的內部購買。該筆交易爲204000美元,購買價格爲每股4.07美元。儘管該購買的價格顯著低於近期價格(4.78美元),但我們仍然認爲內部買入是積極的。因爲股票是在更低的價格下購買的,這筆買入對我們了解內部人士對當前股價的看法幫助不大。
Happily, we note that in the last year insiders paid US$358k for 87.37k shares. On the other hand they divested 20.00k shares, for US$105k. In total, eHealth insiders bought more than they sold over the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
令人欣慰的是,我們注意到在過去的一年裏,內部人士爲87370股支付了358000美元。另一方面,他們出售了20000股,價值105000美元。總的來說,易康的內部人士在過去一年中購買的股份超過了出售的股份。您可以在下面的圖表中查看過去一年內部交易(由公司和個人)情況。通過點擊下面的圖形,您可以查看每筆內部交易的詳細信息!
There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.
還有很多其他的公司,公司的內部人士正在購買股票。你可能不想錯過這個免費的小市值公司的低估列表。
Insider Ownership Of eHealth
易康的內部持股
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. We usually like to see fairly high levels of insider ownership. Our data indicates that eHealth insiders own about US$7.3m worth of shares (which is 5.1% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!
查看公司內部總持股可以幫助你了解他們是否與普通股東有良好的利益一致性。我們通常希望看到相對較高的內部持股水平。我們的數據表明,易康的內部人士持有約730萬美元的股票(佔公司5.1%)。總體而言,這一持股水平並不是很令人印象深刻,但總比沒有好!
So What Does This Data Suggest About eHealth Insiders?
那麼這些數據對易康的內部人士意味着什麼呢?
The insider sales have outweighed the insider buying, at eHealth, in the last three months. In contrast, they appear keener if you look at the last twelve months. But we'd like it if insiders owned more stock, overall. So the company doesn't look great on this analysis. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 3 warning signs for eHealth you should be aware of.
在過去三個月裏,易康的內部出售超過了內部購買。相比之下,如果你看過去十二個月,他們似乎更積極。不過,我們希望內部人士能擁有更多的股票,總體來看公司在這個分析上並不出色。因此,這些內部交易可以幫助我們構建對股票的分析論文,但了解該公司面臨的風險也是值得的。舉個例子:我們發現了易康的3個警告信號,你應該注意。
Of course eHealth may not be the best stock to buy. So you may wish to see this free collection of high quality companies.
當然,易康可能不是最佳的買入股票。因此你可能希望看看這份高質量公司的免費集合。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。